This inventor holds 1 USPTO granted patent and 2 published patent applications and 4 EPO patents. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Hans Iding - Innovator in Pharmaceutical Development
Introduction
Hans Iding is a notable inventor based in Basel, Switzerland. He has contributed to the pharmaceutical industry through his work at prominent companies such as F. Hoffmann-La Roche AG and Genentech, Inc. Although he currently holds no granted patents, his research and development efforts have been significant in advancing medical science.
Latest Patent Applications
Hans Iding's recent patent application focuses on solid forms of a specific compound used in cancer treatment. The application is titled "Solid Forms of 3-((1R,3R)-1-(2,6-Difluoro-4-((1-(3-Fluoropropyl)Azetidin-3-YL)Amino)Phenyl)-3-Methyl-1,3,4,9-Tetrahydro-2H-Pyrido[3,4-B]Indol-2-YL)-2,2-Difluoropropan-1-OL and Processes for Preparing Fused Tricyclic Compounds Comprising a Substituted Phenyl or Pyridinyl Moiety, Including Methods of Their Use." This application outlines the processes and synthesis of the compound, as well as its potential methods of use in treating cancer.
Conclusion
Hans Iding's work in the pharmaceutical field highlights his dedication to innovation and research. His contributions, although not yet reflected in granted patents, demonstrate his commitment to advancing medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile